Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive to BCG Therapy

by | May 15, 2025 | Clinical Trials | 0 comments

​ Conditions: Non Muscle Invasive Bladder Cancer

Interventions: Drug: intravesical Chemotherapy docetaxel/gemcitabine

Sponsors: BLATAM

Not yet recruiting Conditions: Non Muscle Invasive Bladder Cancer
Interventions: Drug: intravesical Chemotherapy docetaxel/gemcitabine
Sponsors: BLATAM
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *